Scarica l'app Stockscreener
5.445
4.14%
-0.235
Dopo l'orario di chiusura:
5.43
-0.015
-0.28%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GBIO Giù?
Forum
Previsione
Precedente Chiudi:
$5.68
Aprire:
$5.61
Volume 24 ore:
133.75K
Relative Volume:
2.21
Capitalizzazione di mercato:
$36.69M
Reddito:
$21.23M
Utile/perdita netta:
$-72.42M
Rapporto P/E:
-0.804
EPS:
-6.7728
Flusso di cassa netto:
$-81.69M
1 W Prestazione:
-2.77%
1M Prestazione:
+6.56%
6M Prestazione:
+61.14%
1 anno Prestazione:
-50.95%
Intervallo 1D:
$5.40
$5.62
Intervallo di 1 settimana:
$5.395
$5.77
Portata 52W:
$3.004
$12.40
Generation Bio Co Stock (GBIO) Company Profile
Nome
Generation Bio Co
Settore
Industria
Telefono
857-529-5908
Indirizzo
301 BINNEY STREET, CAMBRIDGE
Confronta GBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
5.445 | 38.27M | 21.23M | -72.42M | -81.69M | -6.7728 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-16 | Downgrade | Jefferies | Buy → Hold |
| 2025-12-16 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2025-08-13 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-10-19 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-12-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-02-24 | Iniziato | William Blair | Outperform |
| 2021-02-18 | Iniziato | Needham | Buy |
| 2020-07-07 | Iniziato | Cowen | Outperform |
| 2020-07-07 | Iniziato | JP Morgan | Overweight |
| 2020-07-07 | Iniziato | Jefferies | Buy |
| 2020-07-07 | Iniziato | Wedbush | Outperform |
Mostra tutto
Generation Bio Co Borsa (GBIO) Ultime notizie
What analysts say about Generation Bio Co stockMarket Sentiment Extremes & These Picks Are Just One Breakout Away - earlytimes.in
Generation Bio (GBIO) price target decreased by 70.88% to 9.01 - MSN
Jefferies downgrades Generation Bio (GBIO) - MSN
Generation Bio trading halted, news pending - MSN
Patterns Watch: Can Generation Bio Co stock sustain revenue growthTrade Analysis Report & Weekly Stock Performance Updates - moha.gov.vn
How Generation Bio Co. stock reacts to global recession fearsTrade Analysis Summary & Daily Entry Point Trade Alerts - Улправда
Can Generation Bio Co. stock sustain revenue growthJuly 2025 Market Mood & Consistent Growth Equity Picks - DonanımHaber
Brokerages Set Generation Bio Co. (NASDAQ:GBIO) PT at $9.25 - Defense World
Why Generation Bio Co. stock remains on buy listsEarnings Trend Report & Real-Time Volume Triggers - DonanımHaber
Why Generation Bio Co. stock is rated strong buyDividend Hike & Target Return Focused Picks - Улправда
Is Generation Bio Co. stock a safe buy before earningsJuly 2025 Chart Watch & Fast Gaining Stock Reports - Улправда
Can Generation Bio Co. stock sustain institutional interestPortfolio Performance Summary & Daily Chart Pattern Signal Reports - Улправда
Retail Trends: Why Generation Bio Co. stock is rated strong buyJuly 2025 Volume & Long Hold Capital Preservation Tips - Улправда
Generation Bio stock rating reiterated at Market Perform by Citizens - Investing.com South Africa
Generation Bio trading resumes - MSN
Generation Bio announces merger with XOMA Royalty - MSN
Generation Bio stock rating reiterated at Market Perform by Citizens By Investing.com - Investing.com Canada
Generation Bio (NASDAQ:GBIO) Given a $5.50 Price Target at Wedbush - Defense World
Wedbush Upgrades Generation Bio (GBIO) - Nasdaq
Generation Bio (GBIO) Price Target Increased by 13.40% to 30.94 - MSN
Generation Bio (GBIO) Rating Update: Wedbush Upgrades to Outperf - GuruFocus
NodThera appoints Geoff McDonough, M.D., as independent board member - marketscreener.com
GBIO Downgraded by Jefferies with Price Target Cut by 54.55% | G - GuruFocus
‘Zombie’ biotech buyer Xoma to acquire Generation Bio - BioPharma Dive
Wedbush Upgrades Generation Bio to Outperform From Neutral, Adjusts Price Target to $5.50 From $7 - marketscreener.com
Jefferies Downgrades Generation Bio to Hold From Buy, Adjusts Price Target to $5 From $11 - marketscreener.com
Hold Rating on XOMA’s Acquisition of Generation Bio: Balancing Immediate Cash Offer with Potential Future Returns - TipRanks
Jefferies downgrades Generation Bio stock to Hold as XOMA acquisition announced - Investing.com Nigeria
XOMA Strikes Deal To Acquire Generation Bio, Expanding Royalty Portfolio - Nasdaq
XOMA to Acquire Generation Bio (GBIO) in Strategic Merger - GuruFocus
XOMA royalty to acquire Generation Bio - MSN
XOMA Royalty to Acquire Generation Bio - citybiz
The Ademi Firm Investigates Whether Generation Bio Co. Is Obtaining a Fair Price for Its Public Shareholders - 富途牛牛
GBIO Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Generation Bio Co. is Fair to Shareholders - The AI Journal
Generation Bio Announces Merger with XOMA Royalty - TipRanks
Xoma Royalty enters into agreement to acquire Generation Bio - marketscreener.com
Xoma to acquire Generation Bio for $4.2913 per share - TipRanks
XOMA Royalty Corporation to Acquire Generation Bio Co. in Cash Transaction with Milestone and Royalty Opportunities - Quiver Quantitative
Generation Bio (NASDAQ: GBIO) agrees to XOMA cash plus CVR takeover - Stock Titan
XOMA Royalty Enters into Agreement to Acquire Generation Bio - GlobeNewswire
XOMA Royalty Corporation entered into an agreement to acquire Generation Bio Co. for $28.92 million. - marketscreener.com
Published on: 2025-12-14 17:13:04 - moha.gov.vn
Is Generation Bio Co. stock gaining market share2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
How Generation Bio Co. stock performs in weak economyJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - Newser
Generation Bio Stock: A High-Stakes Gamble Between Collapse and Opportunity - AD HOC NEWS
Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing - Via TT
Is Generation Bio Co. stock overvalued by current metricsWall Street Watch & Fast Gaining Stock Strategy Reports - Newser
What catalysts could drive Generation Bio Co. stock higherPrice Action & Free Technical Confirmation Trade Alerts - Newser
Generation Bio (GBIO) Stock Analysis Report | Financials & Insights - Benzinga
Here's Why We're A Bit Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation - Yahoo Finance
Layoff Tracker: Valneva Terminates 30 Amid Site Closure - BioSpace
Generation Bio Co Azioni (GBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Generation Bio Co Azioni (GBIO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Quinn Anthony G. | Director |
Jan 13 '25 |
Buy |
0.97 |
85,000 |
82,450 |
299,286 |
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):